Next Article in Journal
Antispasmodic Activity of Semi-Synthetic Secoisopimarane Derivatives
Previous Article in Journal
SARs of the Antiprotozoal Potency of Diaryl Substituted Bicyclic Bases
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 77
Issue 7
10.3797/scipharm.oephg.21.PO-15
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Antitrypanosomal Activity of 4-Aminobicyclo[2.2.2]octane Derivatives

by
R. WEIS
*,
J. FAIST
and
W. SEEBACHER
Institute of Pharmaceutical Sciences, Karl-Franzens-University of Graz, Universitätsplatz 1, 8010 Graz, Austria
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2009, 77(7), 214; https://doi.org/10.3797/scipharm.oephg.21.PO-15
Submission received: 16 April 2009 / Accepted: 16 April 2009 / Published: 16 April 2009
Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Every year about half a million people are infected with Human African Trypanosomiasis (HAT) and more than 40.000 people die from this disease [1]. Infections with Trypanosoma brucei rhodesiense, which is the more virulent of the two causative organisms, can only be treated with two drugs, suramin and melarsoprol, which can cause severe side effects and which have to be administered by painful injections.[...]

Share and Cite

MDPI and ACS Style

WEIS, R.; FAIST, J.; SEEBACHER, W. Antitrypanosomal Activity of 4-Aminobicyclo[2.2.2]octane Derivatives. Sci. Pharm. 2009, 77, 214. https://doi.org/10.3797/scipharm.oephg.21.PO-15

AMA Style

WEIS R, FAIST J, SEEBACHER W. Antitrypanosomal Activity of 4-Aminobicyclo[2.2.2]octane Derivatives. Scientia Pharmaceutica. 2009; 77(Posters (PO)):214. https://doi.org/10.3797/scipharm.oephg.21.PO-15

Chicago/Turabian Style

WEIS, R., J. FAIST, and W. SEEBACHER. 2009. "Antitrypanosomal Activity of 4-Aminobicyclo[2.2.2]octane Derivatives" Scientia Pharmaceutica 77, Posters (PO): 214. https://doi.org/10.3797/scipharm.oephg.21.PO-15

APA Style

WEIS, R., FAIST, J., & SEEBACHER, W. (2009). Antitrypanosomal Activity of 4-Aminobicyclo[2.2.2]octane Derivatives. Scientia Pharmaceutica, 77(Posters (PO)), 214. https://doi.org/10.3797/scipharm.oephg.21.PO-15

Article Metrics

Back to TopTop